Edelman Saul Eduardo, Guerra Raquel B, Edelman Saul Michelle, Lopes da Silva Laercio, Aleixo Gabriel F P, Matuda Raquel M K, Lopes Gilberto
Department of Medicine, Jackson Memorial Hospital/University of Miami, Miami, FL, USA.
Centro Paulista de Oncologia-Oncoclinicas Group, São Paulo, Brazil.
Nat Cancer. 2020 Dec;1(12):1140-1152. doi: 10.1038/s43018-020-00142-z. Epub 2020 Nov 30.
Lung cancer accounts for an alarming human and economic burden in low- and middle-income countries (LMICs). Recent landmark trials from high-income countries (HICs) by demonstrating that low-dose computed tomography (LDCT) screening effectively reduces lung cancer mortality have engendered enthusiasm for this approach. Here we examine the effectiveness and affordability of LDCT screening from the viewpoint of LMICs. We consider resource-restricted perspectives and discuss implementation challenges and strategies to enhance the feasibility and cost-effectiveness of LDCT screening in LMICs.
肺癌在低收入和中等收入国家(LMICs)造成了惊人的人力和经济负担。高收入国家(HICs)近期的标志性试验表明,低剂量计算机断层扫描(LDCT)筛查可有效降低肺癌死亡率,这引发了人们对该方法的热情。在此,我们从低收入和中等收入国家的角度审视LDCT筛查的有效性和可承受性。我们考虑资源受限的情况,并讨论实施挑战以及提高低收入和中等收入国家LDCT筛查可行性和成本效益的策略。